Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sarah K. Meredith"'
Autor:
Stella M. Fabiane, Chen-Yuan Chiang, Sarah K. Meredith, Meera Gurumurthy, Adamu Bayissa, Andrew J. Nunn, Ruth L. Goodall
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 9, Iss 9, p 211 (2024)
(1) Background: The World Health Organisation (WHO) categorises moxifloxacin and levofloxacin as Group A drugs, which should be prioritised in the treatment of rifampicin-resistant tuberculosis. We compare their relative efficacy and safety using dat
Externí odkaz:
https://doaj.org/article/c22ca3ecff6d4e1e806bc6732c2ab81a
Autor:
Conor D. Tweed, Angela M. Crook, Rodney Dawson, Andreas H. Diacon, Timothy D. McHugh, Carl M. Mendel, Sarah K. Meredith, Lerato Mohapi, Michael E. Murphy, Andrew J. Nunn, Patrick P. J. Phillips, Kasha P. Singh, Melvin Spigelman, Stephen H. Gillespie
Publikováno v:
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background The phase III REMoxTB study prospectively enrolled HIV-positive (with CD4+ count > 250 cells, not on anti-retroviral therapy) and HIV-negative patients. We investigated the incidence of adverse events and cure rates according to H
Externí odkaz:
https://doaj.org/article/d4f6503cd6b943dbb18e73105c9b0eb8
Autor:
Conor D. Tweed, Angela M. Crook, Evans I. Amukoye, Rodney Dawson, Andreas H. Diacon, Madeline Hanekom, Timothy D. McHugh, Carl M. Mendel, Sarah K. Meredith, Michael E. Murphy, Saraswathi E. Murthy, Andrew J. Nunn, Patrick P. J. Phillips, Kasha P. Singh, Melvin Spigelman, Genevieve H. Wills, Stephen H. Gillespie
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background The incidence and severity of tuberculosis chemotherapy toxicity is poorly characterised. We used data available from patients in the REMoxTB trial to provide an assessment of the risks associated with the standard regimen and two
Externí odkaz:
https://doaj.org/article/87ffe9cc14bf494197dd9d05a700110f
Autor:
Michael E. Murphy, Patrick P. J. Phillips, Carl M. Mendel, Emily Bongard, Anna L. C. Bateson, Robert Hunt, Saraswathi Murthy, Kasha P. Singh, Michael Brown, Angela M. Crook, Andrew J. Nunn, Sarah K. Meredith, Marc Lipman, Timothy D. McHugh, Stephen H. Gillespie, On behalf of the REMoxTB Consortium
Publikováno v:
BMC Medicine, Vol 15, Iss 1, Pp 1-10 (2017)
Abstract Background The use of early morning sputum samples (EMS) to diagnose tuberculosis (TB) can result in treatment delay given the need for the patient to return to the clinic with the EMS, increasing the chance of patients being lost during the
Externí odkaz:
https://doaj.org/article/6ed07cb9f278456d91f517953c95470c
Autor:
Laura Rosu, Jason J Madan, Ewan M Tomeny, Malaisamy Muniyandi, Jasper Nidoi, Mamo Girma, Valentina Vilc, Priyanka Bindroo, Rajdeep Dhandhukiya, Adamu K Bayissa, Daniel Meressa, Gopalan Narendran, Rajesh Solanki, Anuj K Bhatnagar, Elena Tudor, Bruce Kirenga, Sarah K Meredith, Andrew J Nunn, Gay Bronson, I D Rusen, S Bertel Squire, Eve Worrall, Saleem Ahmad, Sofia Alexandru, Katharine Bellenger, Tolera G. Bulga, Claire Cook, Valeriu Crudu, Bennet Deborah, Wendy Dodds, Belay A. Gebreegziabher, Ruth L. Goodall, Pritti Gupta, Meera Gurumurthy, Ivor Langley, Joanitah Nalunjogi, Saleem Khan, Saravanan Krishnan, Shravan Kumar, Maia Lesosky, Mariana Macari, Mukesh Makwana, Brendan Murphy, Ramesh P. Murugesan, Vanita Patel, Irina Pirlog, Mary Rauchenberger, Karen Sanders, Ramesh Singh, Sangeetha Subramani, Mekonnen Teferi, Netsanet A. Tegegn, Arun Babu Velmurugan, Johanna Whitney
Publikováno v:
The Lancet. Global health.
The STREAM stage 2 trial assessed two bedaquiline-containing regimens for rifampicin-resistant tuberculosis: a 9-month all-oral regimen and a 6-month regimen containing an injectable drug for the first 2 months. We did a within-trial economic evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e5d210d631d7efaecc3e120c8e9156d
https://pubmed.ncbi.nlm.nih.gov/36565704
https://pubmed.ncbi.nlm.nih.gov/36565704
Autor:
Ruth L Goodall, Sarah K Meredith, Andrew J Nunn, Adamu Bayissa, Anuj K Bhatnagar, Gay Bronson, Chen-Yuan Chiang, Francesca Conradie, Meera Gurumurthy, Bruce Kirenga, Nana Kiria, Daniel Meressa, Ronelle Moodliar, Gopalan Narendran, Nosipho Ngubane, Mohammed Rassool, Karen Sanders, Rajesh Solanki, S Bertel Squire, Gabriela Torrea, Bazarragchaa Tsogt, Elena Tudor, Armand Van Deun, I D Rusen, Oyunchimeg Adilaa, Sofia Alexandru, Katharine Bellenger, Jaclyn Bennet, Deborah Bennet, Priyanka Bindroo, Ghanshyam Borisagar, Claire Cook, Doljinsuren Dalai, Andrew Davis, Bouke de Jong, Wendy Dodds, Lynette Duckworth, Nonhlanhla Gahima, Belay Gebreegziabher, Anne Goldfeld, Mahmud Hanifa, Gareth Hughes, Ivan Kimuli, Jan Komrska, Nino Lomtadze, Brendan Murphy, Thando Mwelase, Joanitah Nalunjogi, Leena Patel, Irina Pirlog, Ishmael Qawiy, Mary Rauchenberger, Leen Rigouts, Carol Roach, Laura Rosu, Ezio Santos-Filho, Thirumaran Senguttuvan, Million Sisay, Rathinam Sridhar, Vignes Srinivasulu, Mekonnen Teferi, Helen Teklu, Narangarav Tsegeen, Odette van Amsterdam, Lisa White, Johanna Whitney, Chuluunbaatar Zagd
Publikováno v:
Lancet (London, England). 400(10366)
The STREAM stage 1 trial showed that a 9-month regimen for the treatment of rifampicin-resistant tuberculosis was non-inferior to the 20-month 2011 WHO-recommended regimen. In STREAM stage 2, we aimed to compare two bedaquiline-containing regimens wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c955b8f2fa408406f893ed06e640c853
https://pubmed.ncbi.nlm.nih.gov/36375483
https://pubmed.ncbi.nlm.nih.gov/36375483
Autor:
Kim S, Thomas, Angela M, Crook, Andrew J, Nunn, Katharine A, Foster, James M, Mason, Joanne R, Chalmers, Ibrahim S, Nasr, Richard J, Brindle, John, English, Sarah K, Meredith, Nicholas J, Reynolds, David, de Berker, Peter S, Mortimer, Hywel C, Williams, Tess, McPherson
Publikováno v:
New England Journal of Medicine. 368:1695-1703
Cellulitis of the leg is a common bacterial infection of the skin and underlying tissue. We compared prophylactic low-dose penicillin with placebo for the prevention of recurrent cellulitis.We conducted a double-blind, randomized, controlled trial in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34bfe667f7e027934a6d53958c516e67
https://doi.org/10.1056/nejmoa1206300
https://doi.org/10.1056/nejmoa1206300
Autor:
Matthew R, Sydes, Anthony L, Johnson, Sarah K, Meredith, Mary, Rauchenberger, Annabelle, South, Mahesh K B, Parmar
Publikováno v:
Trials
Background The move towards increased transparency around clinical trials is welcome. Much focus has been on under-reporting of trials and access to individual patient data to allow independent verification of findings. There are many other good reas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::03c969e3dcc63539f4d7fbaddc83b423
https://pubmed.ncbi.nlm.nih.gov/25872927
https://pubmed.ncbi.nlm.nih.gov/25872927
Autor:
Andrew J, Nunn, I D, Rusen, Armand, Van Deun, Gabriela, Torrea, Patrick P J, Phillips, Chen-Yuan, Chiang, S Bertel, Squire, Jason, Madan, Sarah K, Meredith
Publikováno v:
Trials
Background In contrast to drug-sensitive tuberculosis, the guidelines for the treatment of multi-drug-resistant tuberculosis (MDR-TB) have a very poor evidence base; current recommendations, based on expert opinion, are that patients should be treate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::079f27d364111cceee667f124d89cb24
https://pubmed.ncbi.nlm.nih.gov/25199531
https://pubmed.ncbi.nlm.nih.gov/25199531
Autor:
Amanda J, Welton, Madge R, Vickers, Joseph, Kim, Deborah, Ford, Beverley A, Lawton, Alastair H, MacLennan, Sarah K, Meredith, Jeannett, Martin, Tom W, Meade, S, Rose
Publikováno v:
The BMJ
OBJECTIVE: To assess the effect of combined hormone replacement therapy (HRT) on health related quality of life. DESIGN: Randomised placebo controlled double blind trial. SETTING: General practices in United Kingdom (384), Australia (94), and New Zea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::448bc1b46349679faf5ffc3bf5b517b9
http://europepmc.org/articles/PMC2518695
http://europepmc.org/articles/PMC2518695